Reports
Sale
Global Peritoneal Dialysis Market Share, Size, Growth, Analysis, Forecast: By Treatment Type: Continuous Ambulatory Dialysis Services, Automated Peritoneal Dialysis Services; By Product Type: Peritoneal Dialysis Solutions, Peritoneal Dialysis Devices, Others; By End User; By Treatment Channel; Regional Analysis; Supplier Landscape; 2024-2032
Global Peritoneal Dialysis Market Outlook
The global peritoneal dialysis market size attained a value of nearly USD 4,635.4 million in 2023. The market is likely to grow at a CAGR of 6.4% during the forecast period of 2024-2032 to attain a value of USD 8,105.5 million by 2032.
Key Trends in the Market
With peritoneal dialysis (PD), a soft plastic tube or catheter is surgically implanted into the abdominal lining or belly to treat kidney failure. The two types of peritoneal dialysis are continuous ambulatory peritoneal dialysis (CAPD) and continuous cycling peritoneal dialysis (CCPD). These methods enable more flexible treatment options, lessen the need to visit dialysis facilities, and produce better clinical results, which means less drugs and fewer dietary restrictions.
- Peritoneal dialysis has the benefit that it can be performed at home and does not necessitate frequent journeys to a dialysis facility. Patients undergoing peritoneal dialysis also have less food and fluid restrictions than those undergoing haemodialysis. This is anticipated to increase the demand for peritoneal dialysis and, as a result, fuel the peritoneal dialysis market growth in the upcoming years.
- The rising incidence of diabetes, hypertension, and end-stage renal disease (ESRD), along with the growing need for kidney donors and the growing consumer knowledge of the hazards of kidney transplants, are the primary factors driving the market's expansion.
- The significant increase in chronic kidney disease (CKD) in recent years can be linked to the increasing prevalence of high blood pressure and diabetes. Over time, CKD is worsening and raising the risk of developing heart disease and stroke. This has increased the peritoneal dialysis demand, which is significantly boosting peritoneal dialysis market development.
- The market is further expanding due to a shift in health professionals' preferences for PD over haemodialysis, which offers better patient mobility at affordable costs while producing less symptom variations. Along with this, various government spending on research and development (R&D), improving reimbursement practises, and ongoing product diversification are encouraging the market expansion.
Global Peritoneal Dialysis Market Analysis
Based on treatment type, the market is segmented into continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD). The market on the basis of product can be divided into peritoneal dialysis solution, peritoneal dialysis devices, peritoneal dialysis sets, and peritoneal dialysis catheters, among others. On the basis of end use, the market is divided into home-based dialysis and dialysis centre and hospital-based dialysis. The regional markets for peritoneal dialysis can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the global peritoneal dialysis market, covering their competitive landscape and latest developments like mergers, acquisitions, investments, and expansion plans.
- Baxter International, Inc.
- B. Braun Melsungen AG
- Fresenius Medical Care AG & Co. KGaA
- Medtronic plc
- Medionics International Inc.
- Newsol Technologies Inc.
- Others
Market Share by Treatment Type
The continuous ambulatory peritoneal dialysis (CAPD) market is anticipated to have significant revenue growth during the forecast period. CAPD is a type of peritoneal dialysis that can be done manually, without a machine, and constantly throughout the day. The method is new for the treatment of end-stage renal disease. The benefits include improved blood pressure management, a discernible improvement in anaemia, and an unrestricted diet, thus aiding the peritoneal dialysis market growth.
Additionally, CAPD provides a greater clearance of medicines with a higher molecular weight than haemodialysis. Both therapies are intended to be performed over a 24-hour period, however CAPD does not employ a cycler and APD does. The cycler is a programmable machine that controls the solution exchange, enabling usage of APDs throughout the night while the patient is asleep.
Market Share by Region
North America is anticipated to hold one of the largest market shares during the forecast period. This is due to the high awareness of the peritoneal dialysis technology, the established healthcare industry, and the rising incidence of end-stage renal disease (ESRD) and chronic kidney disease (CKD).
An increase in CKD patients in North America has been caused by the rising numbers of people with diabetes and high blood pressure. This has caused a sharp increase in the demand for peritoneal dialysis among kidney patients, which is anticipated to propel the peritoneal dialysis market in the region. Additionally, the existence of significant producers like Baxter, and other leading producers has improved access to a variety of dialysis products at competitive prices, which is anticipated to fuel the regional market growth.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Competitive Landscape
Baxter International, Inc., which was established in 1931 and has its headquarters in the United States, offers a variety of medical supplies. Its product and service offerings include sterile intravenous solutions, generic injectable medications, parenteral nutrition therapy, infusion systems and devices, inhaled anaesthetics, surgical haemostat and sealant products, and dialysis for both acute and chronic illnesses.
B. Braun Melsungen AG, since its founding in 1839 has developed, produced, and distributed pharmaceutical and medical technology goods as well as offered healthcare services. B. Braun sells equipment and systems for surgery, extracorporeal blood transfusion, intensive care, and anaesthesia. Additionally, it provides services for medical practises, clinics, and the home health care industry.
Fresenius Medical Care AG & Co. KGaA, a global healthcare company with its headquarters in Germany and founded in 1996, provides high-quality goods and services for hospitals, outpatient care, and dialysis, with about 3.8 million patients receiving dialysis on a regular basis globally.
Other market players include Medtronic plc, Medionics International Inc., and Newsol Technologies Inc., among others.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Treatment Type |
|
| Breakup by Product Type |
|
| Breakup by End User |
|
| Breakup by Treatment Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Peritoneal Dialysis Market Overview
3.1 Global Peritoneal Dialysis Market Historical Value (2017-2023)
3.2 Global Peritoneal Dialysis Market Forecast Value (2024-2032)
4 Global Peritoneal Dialysis Market Landscape
4.1 Peritoneal Dialysis: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Peritoneal Dialysis: Product Landscape
4.2.1 Analysis by Treatment Type
4.2.2 Analysis by Product Type
4.2.3 Analysis by End User
5 Global Peritoneal Dialysis Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Peritoneal Dialysis Market Segmentation
6.1 Global Peritoneal Dialysis Market by Treatment Type
6.1.1 Market Overview
6.1.2 Continuous Ambulatory Dialysis Services
6.1.3 Automated Peritoneal Dialysis Services
6.2 Global Peritoneal Dialysis Market by Product Type
6.2.1 Market Overview
6.2.2 Peritoneal Dialysis Solutions
6.2.3 Peritoneal Dialysis Devices
6.2.4 Peritoneal Dialysis Sets
6.2.5 Peritoneal Dialysis Catheters
6.2.6 Others Peritoneal Dialysis Products
6.3 Global Peritoneal Dialysis Market by End User
6.3.1 Market Overview
6.3.2 Home- Based Dialysis
6.3.3 Dialysis Centers & Hospitals
6.3.4 Others
6.4 Global Peritoneal Dialysis Market by Treatment Channel
6.4.1 Market Overview
6.4.2 Public
6.4.3 Private
6.5 Global Peritoneal Dialysis Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Peritoneal Dialysis Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Peritoneal Dialysis Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Peritoneal Dialysis Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Peritoneal Dialysis Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Peritoneal Dialysis Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Clinical Trials Analysis
15.1 Analysis by Trial Registration Year
15.2 Analysis by Trial Status
15.3 Analysis by Trial Phase
15.4 Analysis by Therapeutic Area
15.5 Analysis by Geography
16 Funding and Investment Analysis
16.1 Analysis by Funding Instances
16.2 Analysis by Type of Funding
16.3 Analysis by Funding Amount
16.4 Analysis by Leading Players
16.5 Analysis by Leading Investors
16.6 Analysis by Geography
17 Partnership and Collaborations Analysis
17.1 Analysis by Partnership Instances
17.2 Analysis by Type of Partnership
17.3 Analysis by Leading Players
17.4 Analysis by Geography
18 Supplier Landscape
18.1 DaVita Inc.
18.1.1 Financial Analysis
18.1.2 Product Portfolio
18.1.3 Demographic Reach and Achievements
18.1.4 Mergers and Acquisitions
18.1.5 Certifications
18.2 Baxter
18.2.1 Financial Analysis
18.2.2 Product Portfolio
18.2.3 Demographic Reach and Achievements
18.2.4 Mergers and Acquisitions
18.2.5 Certifications
18.3 B. Braun Melsungen AG
18.3.1 Financial Analysis
18.3.2 Product Portfolio
18.3.3 Demographic Reach and Achievements
18.3.4 Mergers and Acquisitions
18.3.5 Certifications
18.4 Diaverum
18.4.1 Financial Analysis
18.4.2 Product Portfolio
18.4.3 Demographic Reach and Achievements
18.4.4 Mergers and Acquisitions
18.4.5 Certifications
18.5 Nipro
18.5.1 Financial Analysis
18.5.2 Product Portfolio
18.5.3 Demographic Reach and Achievements
18.5.4 Mergers and Acquisitions
18.5.5 Certifications
18.6 Nxstage Medical, Inc.
18.6.1 Financial Analysis
18.6.2 Product Portfolio
18.6.3 Demographic Reach and Achievements
18.6.4 Mergers and Acquisitions
18.6.5 Certifications
18.7 Nikkiso Co., Ltd.
18.7.1 Financial Analysis
18.7.2 Product Portfolio
18.7.3 Demographic Reach and Achievements
18.7.4 Mergers and Acquisitions
18.7.5 Certifications
18.8 Mar Cor Purification
18.8.1 Financial Analysis
18.8.2 Product Portfolio
18.8.3 Demographic Reach and Achievements
18.8.4 Mergers and Acquisitions
18.8.5 Certifications
18.9 Asahi Kasei Medical Co., Ltd.
18.9.1 Financial Analysis
18.9.2 Product Portfolio
18.9.3 Demographic Reach and Achievements
18.9.4 Mergers and Acquisitions
18.9.5 Certifications
18.10 Rockwell Medical
18.10.1 Financial Analysis
18.10.2 Product Portfolio
18.10.3 Demographic Reach and Achievements
18.10.4 Mergers and Acquisitions
18.10.5 Certifications
18.11 Medtronic
18.11.1 Financial Analysis
18.11.2 Product Portfolio
18.11.3 Demographic Reach and Achievements
18.11.4 Mergers and Acquisitions
18.11.5 Certifications
18.12 Dialifegroup
18.12.1 Financial Analysis
18.12.2 Product Portfolio
18.12.3 Demographic Reach and Achievements
18.12.4 Mergers and Acquisitions
18.12.5 Certifications
18.13 JMS Co.Ltd.
18.13.1 Financial Analysis
18.13.2 Product Portfolio
18.13.3 Demographic Reach and Achievements
18.13.4 Mergers and Acquisitions
18.13.5 Certifications
18.14 Atlantic Biomedical
18.14.1 Financial Analysis
18.14.2 Product Portfolio
18.14.3 Demographic Reach and Achievements
18.14.4 Mergers and Acquisitions
18.14.5 Certifications
18.15 3M
18.15.1 Financial Analysis
18.15.2 Product Portfolio
18.15.3 Demographic Reach and Achievements
18.15.4 Mergers and Acquisitions
18.15.5 Certifications
18.16 Allmed Medical Care Holdings Limited.
18.16.1 Financial Analysis
18.16.2 Product Portfolio
18.16.3 Demographic Reach and Achievements
18.16.4 Mergers and Acquisitions
18.16.5 Certifications
18.17 Isopure Corp.
18.17.1 Financial Analysis
18.17.2 Product Portfolio
18.17.3 Demographic Reach and Achievements
18.17.4 Mergers and Acquisitions
18.17.5 Certifications
18.18 C. R. Bard, Inc.
18.18.1 Financial Analysis
18.18.2 Product Portfolio
18.18.3 Demographic Reach and Achievements
18.18.4 Mergers and Acquisitions
18.18.5 Certifications
19 Peritoneal Dialysis Market - Distribution Model (Additional Insight)
19.1 Overview
19.2 Potential Distributors
19.3 Key Parameters for Distribution Partner Assessment
20 Key Opinion Leaders (KOL) Insights (Additional Insight)
21 Company Competitiveness Analysis (Additional Insight)
21.1 Very Small Companies
21.2 Small Companies
21.3 Mid-Sized Companies
21.4 Large Companies
21.5 Very Large Companies
22 Payment Methods (Additional Insight)
22.1 Government Funded
22.2 Private Insurance
22.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The peritoneal dialysis market was valued at USD 4635.4 million in 2023.
The market is expected to grow at a CAGR of 6.4% from 2024 to 2032 to reach a value of USD 8105.5 million by 2032.
The major drivers of the peritoneal dialysis market include the increasing cases of hypertension, diabetes, and end-stage renal disease (ESRD), the growing prevalence of chronic kidney disease (CKD), and the shifting inclination of health practitioners toward PD over haemodialysis.
The extensive investments in research and development activities by governments, improving reimbursement policies, ongoing product diversification, and well-established healthcare sector are the key industry trends propelling the growth of the market.
The major players in the industry are Baxter International, Inc., B. Braun Melsungen AG, Fresenius Medical Care AG & Co. KGaA, Medtronic plc, Medionics International Inc., and Newsol Technologies Inc., among others.
The most typical kind of PD is continuous ambulatory peritoneal dialysis. Self-dialysis of this kind is performed every day of the week, with four to five exchanges of fresh solutions per day.
While the functionality of peritoneal dialysis and haemodialysis are similar, peritoneal dialysis is safer as it can be conducted regularly, preventing build-up of fluids. As haemodialysis requires visits to a centre dialysis, risks of missing appointments and build-ups of fluid is higher.
Infection is one of the most dangerous complications of peritoneal dialysis and can appear in the skin around the catheter or inside the abdominal cavity in the form of peritonitis. The development of a hernia, a weakening in the abdominal muscles, is another potential but less severe side effect of peritoneal dialysis.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$ 3499
$1999
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5999
$2999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 7999
$3999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 9999
$5999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER